ALS Critical Therapies Access
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-16 — Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026: 2026 — Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 (S4472) introduced to reauthorize federal programs expanding ALS patient access to investigational and critical therapies, continuing the existing framework rather than creating a new pathway. (novelty: 2)
Open questions
Related
Contributing findings
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
09-jul-2026
novelty 2
per-area 2
strengthens